Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP AF First Post-Approval Study, an Addendum to the Cryo Global Registry

NCT05227053 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT05227053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP AF First Post-Approval Study, an Addendum to the Cryo Global Registry
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Observational
Overall status
Active, not recruiting
Start date
April 28, 2022
Completion date
October 31, 2026
Enrollment
200 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation